Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Preferred Shares (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Preferred Shares for 3 consecutive years, with $9.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $9.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.6 million, a 0.0% change, with the full-year FY2024 number at $9.6 million, down 2.95% from a year prior.
  • Preferred Shares was $9.6 million for Q3 2025 at 60 Degrees Pharmaceuticals, roughly flat from $9.6 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $9.9 million in Q3 2023 to a low of $9.6 million in Q3 2024.
  • A 3-year average of $9.7 million and a median of $9.6 million in 2024 define the central range for Preferred Shares.
  • Peak YoY movement for Preferred Shares: dropped 2.95% in 2024, then changed 0.0% in 2025.
  • 60 Degrees Pharmaceuticals' Preferred Shares stood at $9.9 million in 2023, then decreased by 2.95% to $9.6 million in 2024, then changed by 0.0% to $9.6 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Preferred Shares are $9.6 million (Q3 2025), $9.6 million (Q2 2025), and $9.6 million (Q1 2025).